European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F23%3A00013573" target="_blank" >RIV/00023736:_____/23:00013573 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1038/s41375-023-02048-y" target="_blank" >https://doi.org/10.1038/s41375-023-02048-y</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/s41375-023-02048-y" target="_blank" >10.1038/s41375-023-02048-y</a>

Result language
angličtina
Original language name
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
Original language description
From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to critically consider the current status of genetic laboratory approaches to help diagnose and manage CML patients. Our recommendations focus on current best practice and highlight the strengths and pitfalls of commonly used laboratory tests.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)